Sarepta Therapeutics
SRPT
SRPT
329 hedge funds and large institutions have $5.49B invested in Sarepta Therapeutics in 2022 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 96 increasing their positions, 129 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.03% more ownership
Funds ownership: 83.78% → 83.81% (+0.03%)
4% less capital invested
Capital invested by funds: $5.7B → $5.49B (-$215M)
26% less repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 129
Holders
329
Holding in Top 10
9
Calls
$130M
Puts
$77.9M
Top Buyers
| 1 | +$59.9M | |
| 2 | +$36.5M | |
| 3 | +$35.6M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$30M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$27.4M |
Top Sellers
| 1 | -$80.3M | |
| 2 | -$76.6M | |
| 3 | -$24.2M | |
| 4 |
VCP
Varenne Capital Partners
Paris,
France
|
-$23.1M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$21M |